Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $94.25, a high estimate of $126.00, and a low estimate of $70.00. This current ...

UroGen Pharma has opened another front in its attack on bladder cancer, paying IconOVir Bio $4 million in stock for an ...

ImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...

What Happened? Shares of biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) jumped 9.6% in the pre-market session after ...

FHI 360 is conducting a fully-funded Phase 1 trial to investigate pharmacokinetics, removability, safety and tolerability of Casea S with support from a foundation grant (ClinicalTrials.gov ID: ...

Luddy School of Informatics, Computing and Engineering, and School of Science, all at IU Indianapolis. Photo by Liz Kaye, Indiana University ...

Headquartered in Wexford, PA, COEPTIS is dedicated to advancing its mission within the regulatory framework set forth by the FDA, ensuring that all activities align with the highest standards of ...

With MarketLeverage’s extensive industry expertise and NexGenAI Affiliates Network’s innovative AI-powered platform, this collaboration will empower affiliates, brands, and marketers with advanced ...

BioMarin exceeded Q4 earnings expectations, raised 2025 guidance, and projected strong Voxzogo growth. Analysts increased price targets following the results.

Looking for a biopharma job in Pennsylvania? Check out the BioSpace list of six companies hiring life sciences professionals ...

Why did “ Biotech is in a dark place ” resonate with so many of you? Because it’s true! Collectively, we’re all frustrated ...